Relfydess is the brand name for relabotulinumtoxinA, a neuromodulator developed by Galderma. Like other cosmetic injections in this category, it is designed to temporarily reduce movement in selected facial muscles that contribute to expression lines.

The primary difference is its ready-to-use liquid formulation. Relfydess does not require preparation before injection, which is different from many established neuromodulators.

Current research has focused on two areas:

• Frown lines between the eyebrows
• Crow’s feet around the eyes

Relfydess is not currently being offered for treatment at Carolina Facial Plastics.

Both Relfydess and Botox Cosmetic® are neuromodulators designed to temporarily reduce expression lines by treating selected facial muscles. Botox Cosmetic is an established option currently available at Carolina Facial Plastics, while Relfydess is still awaiting FDA approval in the United States.

The main difference discussed so far is formulation. Relfydess is a ready-to-use liquid neuromodulator from Galderma, while Botox Cosmetic has its own established formulation, approved uses, dosing approach, and treatment history.

A direct Relfydess vs Botox comparison for United States patients will become clearer after FDA approval and official United States prescribing information are available. Treatment decisions should always be based on facial movement, treatment goals, anatomy, and the approved uses of each product.

Dr. Jonathan Kulbersh stays informed about the latest developments in cosmetic injections and facial aesthetics. New treatments are considered carefully, with attention to clinical research, patient safety, and whether they can support natural-looking results.

At Carolina Facial Plastics, patients can currently explore established neuromodulator options such as Botox Cosmetic, Dysport®, and Daxxify®. Each option is selected based on the individual treatment area, facial movement, and aesthetic goals.

Explore Current Injectable Treatments